Introduction: Cardiac Insufficiency is progressively taking over as the leading cause of morbidity and mortality in the world and a major public health problem in Chad. Our study was to contribute and provide a deeper understanding of the clinical and etiological aspects concerning the etiology and management of Cardiac Insufficiency in N'Djamena, Chad. Due to having no published data to distinctly understand this pathology in this part of the world, we represent here a summary of available data which could be used to describe the clinical and etiological aspects of Cardiac Insufficiency and to help in changing practices for an optimal management as a baseline for comparison in future studies. Patients and Methods: This was a prospective, descriptive study conducted from November 30th 2011 to May 30th 2013 at the Good Samaritan Hospital of N'Djamena. Results: 100 hospitalized patients were included consecutively. The sex ratio was 1.08 with an average age of 40.21 ± 21.30 years. The main cardiovascular risk factors were high blood pressure (15%), obesity (12%) and diabetes (11%). Clinically, exertional dyspnea was found in 95% of cases, and signs of congestive heart failure in 61% of cases. The etiologies were 50% of Rheumatic valvulopathy, 22% of Dilated cardiomyopathy, 13% of Hypertensive cardiomyopathy and 12% of Congenital heart disease. Conclusion: The most common etiologies were Rheumatic valvulopathy, Congenital heart disease, Dilated cardiomyopathy and Hypertensive cardiomyopathy.
Introduction
Cardiac Insufficiency (CI) is a common pathology worldwide. It is a clinical syndrome characterized by chronic symptoms (e.g. dyspnea, fatigue) that may be accompanied by physical signs (e.g. crepitations, peripheral edema) caused by a structural and/or functional cardiac abnormality, which causes a decrease in cardiac output [1] . CI is a major global public health problem affecting 40 million people worldwide in 2015 [2] . CI represents one of the leading causes of hospitalization, morbidity and mortality, especially among the elderly [3] . In western countries, the incidence and prevalence of CI are increasing due to the aging of the population [1] . The prevalence was estimated at 1% -2% of the adult population [1] [4] , while the incidence rate is generally estimated at 2 to 5 per 1000 people annually [5] [6] . In Africa, CI is one of the main circumstances in the discovery of cardiovascular disease with an incidence of 1 to 3 per 1000 people annually and a prevalence of 3 to 20 per 1000 people annually, often at an advanced stage [7] . According to World Health Organization estimates, cardiovascular disease is the second leading cause of death in Africa. In 2015, nearly 1.2 million people died of heart disease in Africa, which is more than Malaria and Tuberculosis combined [8] . Despite improvements observed in the survival of patients with CI in recent years, overall prognosis remains poor [3] [9] with 50% survival estimates at 5 years after initial CI diagnosis [10] [11] . However, in Chad, we do not have data on this pathology. The objective of this work was to identify the etiology of CI in Chad.
Patients and Methods
This was a study conducted from November 30th 2011 to May 30th 2013 at the Good Samaritan Hospital of N'Djamena. We consecutively included all the patients that were hospitalized for CI during this study period. Patients who refused to give their consent were excluded. There were no specific selection criteria. The variable studies were clinical (history, cardiovascular risk factors, functional signs, physical signs), biological (HIV serology, blood count, thyroid hormone, serum creatinine, blood urea, electrolyte panel, blood glucose) and echocardiographic (dilation, hypertrophy and left ventricular ejection fraction, valvular abnormalities, pulmonary arterial pressures, and pericardial abnormalities).
The system used was the HP 1000 ET 5500 model. The following parameters were specified: • Dilation of the Left Ventricle In this study, a descriptive statistical analysis was applied using Microsoft Excel, quantitative variables were presented by their mean and standard deviation and qualitative variables were by percentages.
Declaration of ethics The study was conducted after an agreement of the Ethics Committee of the Faculty of Medicine of N'Djamena and with the consent of patients.
Results
100 patients were included. Table 1 summarizes the characteristics of this population. The sex ratio was 1.08 (52 men) with an average age of 40.21 ± 21.30 years with a predominance of patients aged 20 to 29 years and those with an age greater than or equal to 50 years of age. The main cardiovascular risk factors were high blood pressure (15%), obesity (12%) and diabetes (11%). Other risk factors identified were dyslipidemia (02%), alcohol (10%), smoking (04%), and renal dysfunction (09%).
Clinically (Table 2) , exertional dyspnea was observed in 95% of cases, and the signs of global CI were 61% of cases. Regarding the etiologies of CI (Table 3) Table 3 presents the etiologies of CI by age group (Figure 1 ).
Discussion
CI is a global public health problem. In Chad, we do not have epidemiological data on this pathology. In this study the mean age was 40.21 ± 21.30 years and more than half of our patients were under 50 years of age. Several authors in Sub-Saharan Africa have found similar results [12] [13] [14] . In the West, according to the Framingham Cohort study, the average age was 70 [15] . This difference in the average age with the West, is related to the lack of medical coverage and the reduced life expectancy at home. The leading cardiovascular risk [23] . Ischemic heart disease was rare (7.2%) [23] . The size of our sample was not representative to assert the rarity of ischemic heart disease in Ndjamena, Chad. Further studies will be needed to provide an answer to this trend. However, according to age groups, our study revealed a clear predominance of Rheumatic heart disease and Congenital heart disease in children and young adults (<30 years of age). The dilated cardiomyopathies and the hypertensive heart diseases mainly affected adults beyond 30 years of age.
Limitations of Our Study
The sample size of our study is not significant enough to reach formal conclusions. In this study, we did not include the therapeutic and evolutionary aspect
